SEC reporting owner

Polaris Venture Partners Special Founders' Fund V, L.P. SEC insider disclosures

Explore Polaris Venture Partners Special Founders' Fund V, L.P.'s reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001439586
Issuers
17
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Issuer relationships

Polaris Venture Partners Special Founders' Fund V, L.P.: source evidence dated 2026-10-07T00:29:11.873Z.

Issuer
INTERNET BRANDS, INC.
CIK
0001080131
Tickers
INET
Officer
No
Director
No
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

See the complete issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

INTERNET BRANDS, INC.0001080131INETNoNo
BIND Therapeutics, Inc0001385228BINDNoNo
FATE THERAPEUTICS INC0001434316FATENoNo
TREVENA INC0001429560TRVNNoNo
GENOCEA BIOSCIENCES, INC.0001457612GNCANoNo
Cerulean Pharma Inc.0001401914CERUNoNo
OCULAR THERAPEUTIX, INC0001393434OCULNoNo
T2 Biosystems, Inc.0001492674TTOONoNo
aTYR PHARMA INC0001339970LIFENoNo
Pulmatrix, Inc.0001574235PULMNoNo
SELECTA BIOSCIENCES INC0001453687SELBNoNo
Kala Pharmaceuticals, Inc.0001479419KALANoNo
Arsanis, Inc.0001501697ASNSNoNo
Cardlytics, Inc.0001666071CDLXNoYes
Phreesia, Inc.0001412408PHRNoNo
Lyra Therapeutics, Inc.0001327273LYRANoNo
Adagio Therapeutics, Inc.0001832038ADGINoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.